FDA Adds Strict Safety Warnings on Arthritis Drugs From Pfizer, AbbVie and Lilly

The U.S. health regulator has added its strictest warning to the labels of drugs from Pfizer, Eli Lilly and AbbVie belonging to a class of anti-inflammatory treatments called JAK inhibitors, citing risk of serious health issues and death in patients 50 and over, the drugmakers said on Friday. Read More